E. Schweizer et al., THE EFFECT OF PERSONALITY ON WITHDRAWAL SEVERITY AND TAPER OUTCOME INBENZODIAZEPINE DEPENDENT PATIENTS, Psychological medicine, 28(3), 1998, pp. 713-720
Background. Personality psychopathology exerts a significant and indep
endent effect on the course of benzodiazepine (BZ) discontinuation, wo
rsening the subjective severity of withdrawal symptoms and significant
ly increasing the occurrence of early taper failures. Method. One hund
red and seventy-one patients participating in a BZ discontinuation pro
gramme were administered several personality measures prior to taper.
Patients were stabilized for 3 weeks at their baseline BZ dosage and t
hen tapered off 25% per week over 4 weeks, with the option to extend u
p to 6 weeks if necessary. Results. High levels of passivity and depen
dency as assessed by the MMPI Dependence subcluster, and at a trend le
vel high Eysenck Neuroticism and high TPQ Harm Avoidance contributed s
ignificantly to the prediction of benzodiazepine withdrawal severity.
Though there was a high correlation between personality measures, psyc
hopathology and adjusted BZ dose, the effects of personality on withdr
awal severity was significant, particularly in the initial phases of B
Z taper, when taper severity was still relatively mild. Conclusions. T
hese findings indicate that clinical decisions on how to manage BZ tap
ering should be guided by personality assessments, in addition to the
usual considerations of BZ dosage, residual psychopathology, duration
of treatment, etc. The potential for difficulty with discontinuation r
elated to personality traits should be one of the factors weighed in t
he risk-benefit assessment made in the planning of benzodiazepine trea
tment for patients with anxious symptomatology.